Unknown

Dataset Information

0

Modified silicone stent for difficult-to-treat massive hemoptysis: a pilot study of 14 cases.


ABSTRACT: Background:Massive hemoptysis is a life-threatening event with limited therapeutic options. Bronchoscopic placement of stents may offer an alternative option for massive hemoptysis. However, traditional silicone stents have not been customized, making it difficult to tailor to individual patient's needs for achieving optimal hemostasis. To investigate the efficacy and safety of the modified silicone stent in patients with difficult-to-treat massive hemoptysis. Method:Between May 2016 and November 2018, we enrolled 14 patients who underwent bronchoscopic placement of the modified silicone stent, which was fabricated manually based on the Y-shaped silicone stent by tailoring and suturing on site. We recorded the technical success, clinical success, and complications. Patients were followed up for recording the recurrence of massive hemoptysis and complications. Results:Placement of the modified silicone stent was successful in all 14 patients with a mean duration of 69.6 minutes (technical success rate: 100%). After stenting, no further massive hemorrhage episodes recurred in 12 patients (clinical success rate: 85.7%). Two cases suffered from recurrent hemoptysis in 4 and 6 days after stenting, respectively. The main complications were sputum plugging, granuloma proliferation and pulmonary infection such as pneumonia. There were no adverse events of stent migration and suture dehiscence. After a median follow-up of 5.8 (range, 0.3-21.3) months, three patients withdrew and seven patients succumbed. Only one patient died of uncontrolled pneumonia which was possibly related to stent placement. Conclusions:The modified silicone stent is an effective and safe gate-keeping therapeutic option for difficult-to-treat massive hemoptysis.

SUBMITTER: Zeng J 

PROVIDER: S-EPMC7139086 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Modified silicone stent for difficult-to-treat massive hemoptysis: a pilot study of 14 cases.

Zeng Junli J   Wu Xuemei X   Zhang Meihua M   Lin Liancheng L   Ke Mingyao M  

Journal of thoracic disease 20200301 3


<h4>Background</h4>Massive hemoptysis is a life-threatening event with limited therapeutic options. Bronchoscopic placement of stents may offer an alternative option for massive hemoptysis. However, traditional silicone stents have not been customized, making it difficult to tailor to individual patient's needs for achieving optimal hemostasis. To investigate the efficacy and safety of the modified silicone stent in patients with difficult-to-treat massive hemoptysis.<h4>Method</h4>Between May 2  ...[more]

Similar Datasets

| S-EPMC7789393 | biostudies-literature
| S-EPMC7305531 | biostudies-literature
| S-EPMC6888868 | biostudies-literature
| S-EPMC8647245 | biostudies-literature
| S-EPMC5937817 | biostudies-other
| S-EPMC6358378 | biostudies-literature
| S-EPMC8041787 | biostudies-literature
| S-EPMC9452433 | biostudies-literature
| S-EPMC2727897 | biostudies-other
| S-EPMC3041922 | biostudies-literature